ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AQST Aquestive Therapeutics Inc

3.97
0.06 (1.53%)
Apr 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,344,814
Bid Price 3.96
Ask Price 3.99
News -
Day High 4.10

Low
1.15

52 Week Range

High
6.23

Day Low 3.83
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 1.53% 3.97 19:59:16
Open Price Low Price High Price Close Price Prev Close
4.05 3.83 4.10 3.94 3.91
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,428 1,344,814 $ 3.92 $ 5,270,166 - 1.15 - 6.23
Last Trade Time Type Quantity Stock Price Currency
19:59:16 formt 200 $ 3.97 USD

Aquestive Therapeutics (AQST) Options Flow Summary

Overall Flow

Bullish

Net Premium

103k

Calls / Puts

100.00%

Buys / Sells

50.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

Aquestive Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
288.07M 73.30M - 50.58M -7.87M -0.11 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aquestive Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AQST Message Board. Create One! See More Posts on AQST Message Board See More Message Board Posts

Historical AQST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.104.383.754.032,109,968-0.13-3.17%
1 Month6.236.233.754.353,208,852-2.26-36.28%
3 Months2.466.232.324.222,400,3681.5161.38%
6 Months1.546.231.36643.831,392,8042.43157.79%
1 Year1.286.231.153.38913,7892.69210.16%
3 Years4.406.400.6182.94664,944-0.43-9.77%
5 Years6.1410.000.6184.04678,140-2.17-35.34%

Aquestive Therapeutics Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Your Recent History

Delayed Upgrade Clock